Sales and Marketing

Showing 15 posts of 11524 posts found.

merckincweb2

MSD’s ulcerative colitis drug scores expanded indication in Europe

July 9, 2018 Sales and Marketing Europe, MSD, pharma, ulcerative colitis

New Jersey-based multinational MSD have announced that the European Commission (EC) has approved Simponi (golimumab) for early dose optimisation in …

Eisai and Biogen’s Alzheimer’s drug slows progression in Phase 2 trials

July 9, 2018 Research and Development, Sales and Marketing

The Japan-based Eisai and Massachusetts-based Biogen have announced that experimental drug BAN2401 has demonstrated efficacy in slowing the progression of …
shutterstock_212035546

Extended use of breast cancer drug tamoxifen linked to increased endometrial cancer risk

July 9, 2018 Research and Development, Sales and Marketing Cancer, breast cancer, endometrial cancer, pharma, tamoxifen

New evidence published in the British Journal of Surgery has indicated a troubling link between long-term use of the breast …

Insider Interview: Biosimilars to balance the books

July 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, bisoimilars, multiple sclerosis

Jean-Yves Brault, Country Manager at Mylan UK, discusses how biosimilars are going to play an important role in driving down …

Scotland approves first-line treatment for advanced kidney cancer

July 9, 2018 Sales and Marketing Cancer, Scotland, fotivda, rcc, tivozanib

The Scottish Medicines Consortium has approved the use of EUSA Pharma’s Fotivda (tivozanib) as a first-line treatment for people with …
shutterstock_114045100

Regulus cuts workforce by 60%, halts studies in major restructure

July 9, 2018 Sales and Marketing Regulus, pharma

California-based biotech Regulus Therapeutics has announced it is to strip away more than half of its total workforce as part …

Missouri appeals court overturns $55m J&J verdict

July 6, 2018 Medical Communications, Sales and Marketing Cancer, J&J, JJ, Litigation, appeal, pharma

A $55 million verdict against the multinational pharmaceutical company Johnson & Johnson has been overturned by an appeals court in …
kymriah

CHMP recommends Novartis’ CAR-T therapy Kymriah for EU approval

July 5, 2018 Sales and Marketing CAR-T, CHMP, EMA, EU, Kymriah, Novartis, pharma

The Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Medicines Agency (EMA) approve Novartis’ CAR-T …
Cow in field

Global animal health market set to be worth $44.2 billion by 2020

July 5, 2018 Manufacturing and Production, Sales and Marketing Antibiotics, agriculture, animal, health, meat, pharma

The global animal health market is predicted to reach a value of $44.2 billion dollars by 2020, according to analysts …
takeda_usa_pharmaceuticals_u

Takeda to sell Osaka site to soften Shire deal’s financial impact

July 5, 2018 Manufacturing and Production, Sales and Marketing Japan, Osaka, Shire, Takeda, acquisition, pharma

It’s one of the biggest acquisitions the industry has seen at a total value of $63 billion and after weeks …
opdivo_1_1

NICE turns down BMS’ blockbuster Opdivo for urothelial carcinoma

July 5, 2018 Sales and Marketing BMS, Bristol-Myers Squibb, NICE, opdivo, pharma, urothelial carcinoma

Just in time for the NHS’ 70th birthday, UK watchdog NICE has announced that it has taken the decision to …
money-pills-pharma-file

GSK Director indicted in Massachusetts opioid lawsuit

July 4, 2018 Research and Development, Sales and Marketing

The state of Massachusetts has taken action to sue a board member at GlaxoSmithKline for her alleged role in fuelling …
deborah_standing_cropped_web

Lundbeck appoints new President and CEO

July 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ludbeck, pharma

The Danish pharmaceutical company Lundbeck has announced that the company’s Board of Directors have appointed Dr Deborah Dunshire as Lunbeck’s …
The Gateway to Local Adoption Series

Latest content